Nanomedicine : nanotechnology, biology, and medicineAnimalsMyocarditisExosomesMiceEnterovirus B
Dual-targeting exosome vaccine confers efficient protection against CVB3-induced myocarditis.
Qinghui Cao, Yihui Ge, Tong Wang, Ke Lin, Sidong Xiong, Yan Yue
Published: 202510.1016/j.nano.2025.102865
Abstract
Coxsackievirus B3 (CVB3) is a common cause of viral myocarditis, necessitating the development of prophylactic vaccines.. AD-Exo, a dual-targeting exosome vaccine, was developed to induce immune responses via targeting draining lymph nodes (dLNs) and…
Preview only. Read the full abstract at the source